Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on "Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C".

Journal

Clinical and molecular hepatology

Journal Volume

31

Journal Issue

2

Start Page

658

End Page

661

ISSN

2287-285X

Date Issued

2025-04

Author(s)

Chang, Yu-Ping

DOI

URI

Subjects

Dyslipidemia

FIB-4 index

Hepatitis C virus

Liver stiffness measurement

Type 2 diabetes

Type

editorial